Advertisement

Topics

The Hartford Income Shares Fund, Inc. Company Profile

14:07 EST 9th December 2018 | BioPortfolio

This press release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act, with respect to the fund’s future financial or business performance, strategies or expectations. Forward-looking statements are subject to numerous assumptions, risks and uncertainties, which change over time. Forward-looking statements speak only as of the date they are made, and The Hartford assumes no duty to and does not undertake to update forward-looking statements. Actual results could differ materially from those anticipated in forward-looking statements and past performance is not an indication of future performance. We assume no obligation to update this release, which speaks as of the date issued.


News Articles [621 Associated News Articles listed on BioPortfolio]

TwentyFour Select Monthly Income Fund - Issue of Equity

27 November 2018 TWENTYFOUR SELECT MONTHLY INCOME FUND LIMITED (a non-cellular company limited by shares incorporated in the Island of Guernsey under the Companies (Guernsey) Read more...

In Connecticut, Hartford Health is Ahead of the E-Prescribing Curve

Rajiv LeventhalConnecticut has joined just a handful of states that have passed electronic prescribing mandates. Hartford Health’s CMIO discusses the process in meeting the requirement and the resul...

CVS will keep Aetna headquarters for next decade

CVS Health will keep Aetna’s headquarters in Hartford, Connecticut, for at least 10 years following the completion of its $69 billion merger with Aetna, The Hartford Courant reported.

RECORDATI ANNOUNCES SALES AND MARGIN GROWTH IN THE FIRST HALF 2018. REVENUES +6.9%, OPERATING INCOME +14.1%, NET INCOME +11.7%

RECORDATI ANNOUNCES SALES AND MARGIN GROWTH IN THE FIRST HALF 2018. REVENUES +6.9%, OPERATING INCOME +14.1%, NET INCOME +11.7%.   Consolidated revenues € 696.1 million, +6.9%.EBITDA (1) € 260....

RECORDATI ANNOUNCES SALES AND MARGIN GROWTH IN THE FIRST NINE MONTHS 2018. REVENUES +5.1%, EBITDA +11.1%, OPERATING INCOME +9.6%, NET INCOME +8.2%. INTERIM DIVIDEND € 0.45 (+7.1%)

RECORDATI ANNOUNCES SALES AND MARGIN GROWTH IN THE FIRST NINE MONTHS 2018. REVENUES +5.1%, EBITDA +11.1%, OPERATING INCOME +9.6%, NET INCOME +8.2%. INTERIM DIVIDEND € 0.45 (+7.1%). Consolidated r...

Hartford HealthCare Taps Innovaccer’s Healthcare Data Platform to Connect Over 70 Ambulatory Practice Sites

Hartford HealthCare, Connecticut’s most comprehensive healthcare network, has partnered with the leading San Francisco-based healthcare data platform company, Innovaccer Inc., to leverage data as a ...

How This VC Aligns Her Networking With Her Fund's Investment Thesis

In a networking example of high quality over mass quantity, venture capitalist Brenda Irwin shares insights on how she's engaging prospective investors for her active living fund in a way that aligns ...

PTV News: Dec 4, 2009

Top stories on December 4th, 2009: "Take it or leave it" - Biogen's final offer to Facet Why Novartis should buy out Alcon’s minority shareholders Vertex sells shares to fund drug development Act...

PubMed Articles [118 Associated PubMed Articles listed on BioPortfolio]

Establishing the First Hartford Consensus-Compliant Medical School in the USA.

Following the Hartford Consensus meetings, the Stop the Bleed Campaign was created to reduce the prevalence of death from exsanguination in the case of traumatic hemorrhage. The campaign revolves arou...

UK newspaper reporting of the NHS cancer drugs fund, 2010 to 2015: a retrospective media analysis.

Objective We wished to explore how UK national newspapers had covered the creation and operation of the Cancer Drugs Fund from 2010 to 2015. This was introduced to provide cancer patients in England w...

MULTIDISCIPLINARY AND MOTIVATIONAL INTERVENTION FOR THE TREATMENT OF LOW INCOME BRAZILIAN OBESE ADOLESCENTS: PILOT STUDY.

To test a multidisciplinary and motivational intervention for the treatment of Brazilian obese and low-income adolescents (Z score>2 BMI-for-age) that used nutritional counseling without dietary contr...

Concerning A Service Commitment to Fund Your Medical Education.

NASN 2018 Endowment Fund-Raising Activities.

Clinical Trials [77 Associated Clinical Trials listed on BioPortfolio]

Examine the Feasibility of a Standardized Field Test for Marijuana Impairment: Laboratory Evaluations

Marijuana is one of the most widely used substances. This study will characterize the persistence of cannabis' (CNB's) acute effects on cognitive test performance and simulated driving ove...

Stivarga Real Life Evidence in Hungary

The study aims to evaluate use of regorafenib in clinical practice in Hungary. The study should provide information about clinical characteristics of Hungarian regorafenib patients as well...

Effectiveness Study During the First 1,000 Days in Kenya

Malnutrition is a public health problem in Kenya, with 26% of children underfive years of age stunted, and 26% of pre-school children, 26% of women of reproductive age and 42% of pregnant ...

Cluster Randomized, Parallel-group, Prospective, Follow-up Effectiveness Study in Kenyan Children 6-35 Months

Malnutrition is a public health problem in Kenya, with 26% of children under-five years of age stunted, and 26% of pre-school children, 26% of women of reproductive age and 42% of pregnant...

Enhanced Recovery After Surgery in Laparoscopic Sleeve Gastrectomy

While laparoscopic sleeve gastrectomy (LSG) has become the most commonly performed bariatric surgery procedure in the US and worldwide, it is associated with significant postoperative naus...

Companies [700 Associated Companies listed on BioPortfolio]

The Hartford Income Shares Fund, Inc.

This press release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act, with respect to the fund’s future financial or b...

BioPharma Fund

BioPharma Fund is an investment fund that invests in shares of medical biotechnology companies. Biotechnology companies are developing new drugs for many diseases such as cancer, heart disease, diabet...

The Hartford Financial Services Group, Inc.

Celebrating 200 years of helping its customers achieve what's ahead, The Hartford (NYSE: HIG) is an insurance and wealth management company. Through its unique focus on customer n...

The Hartford

The Hartford is one of the few companies in the United States with in-house experts on aging. For over 25 years, The Hartford has employed gerontologists to advance the creation a...

The Hartford Financial Services Group Inc.

The Hartford Financial Services Group Inc. (NYSE: HIG) is a leading provider of insurance and wealth management services for millions of consumers and businesses worldwide. A Fort...

More Information about "The Hartford Income Shares Fund, Inc." on BioPortfolio

We have published hundreds of The Hartford Income Shares Fund, Inc. news stories on BioPortfolio along with dozens of The Hartford Income Shares Fund, Inc. Clinical Trials and PubMed Articles about The Hartford Income Shares Fund, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of The Hartford Income Shares Fund, Inc. Companies in our database. You can also find out about relevant The Hartford Income Shares Fund, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record